Lifecore Biomedical (NASDAQ: LFCR) will report financial results for its second quarter ended June 30, 2026, on Wednesday, August 5, 2026, before the market opens.
Senior management will host a webcast at 8:00 a.m. Eastern Time, accessible live and on-demand for 30 days via the Investor Events & Presentations page on the company’s website.
Loading...
Loading translation...
Positive
None.
Negative
None.
Market Context
LFCR's two prior earnings-date notices generated +2.63% and -1.15% 24-hour reactions, a mixed record...
Analysis
LFCR's two prior earnings-date notices generated +2.63% and -1.15% 24-hour reactions, a mixed record. The current announcement sets timing, not results; the unresolved risk is whether reported performance changes the platform's prior earnings pattern.
Fourth-quarter and transition-period results announcement scheduled before market open
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
LFCR's tag-matched earnings-date announcements showed mixed 24-hour reactions, with one positive and one negative.
Key Terms
cdmo, fill and finish, hyaluronic acid
3 terms
cdmotechnical
"contract development and manufacturing organization (“CDMO”)"
A contract development and manufacturing organization (CDMO) is a company that provides specialized services to help develop and produce pharmaceutical products for other businesses. Think of it as a contract factory that takes a company's recipe and makes the product on their behalf. For investors, CDMOs are important because they support the growth of pharmaceutical companies and can be key partners in bringing new medicines to market.
fill and finishtechnical
"capabilities in the development, fill and finish of sterile injectable"
The final stage of producing biological medicines where bulk drug substance is transferred into final dosage forms—filling vials, syringes, or cartridges—and then sealed, labeled and packaged for distribution. It matters to investors because this step determines how quickly a treatment can reach patients, creates manufacturing bottlenecks or capacity value, and often involves specialized facilities and regulatory controls; think of it as the bottling and labeling line in a beverage plant that readies product for sale.
hyaluronic acidmedical
"manufacturer of premium, injectable-grade hyaluronic acid"
A naturally occurring molecule that acts like a tiny sponge, holding water in skin, joints and eyes to keep tissues plump and lubricated. Investors track products containing hyaluronic acid because they power large markets—such as skincare, injectable fillers, eye drops and wound treatments—so demand, regulatory approvals, manufacturing capacity and raw-material costs can meaningfully affect a company’s sales and profit outlook.
Webcast Scheduled for Wednesday, August 5 at 8:00 a.m. Eastern
CHASKA, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, before the market opens. At 8:00 a.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss the results.
To listen to the live webcast, or access the archived webcast, please visit the Investor Events & Presentations page of Lifecore’s website at: https://ir.lifecore.com/events-presentations. Following the live webcast, an archived version of the webcast will be available on the company’s website for 30 days.
About Lifecore Biomedical Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated injectables contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
Lifecore Biomedical, Inc. Contact Information:
Vida Strategic Partners Stephanie Diaz (Investors) 415-675-7401 sdiaz@vidasp.com
When will Lifecore Biomedical (NASDAQ: LFCR) report Q2 2026 earnings?
Lifecore Biomedical will report financial results for its second quarter ended June 30, 2026, on Wednesday, August 5, 2026, before the market opens. According to Lifecore, the release will precede a management webcast that morning.
What time is Lifecore Biomedical’s Q2 2026 earnings webcast on August 5, 2026?
Lifecore Biomedical’s Q2 2026 webcast is scheduled for 8:00 a.m. Eastern Time on August 5, 2026. According to Lifecore, senior management will discuss the quarterly results during this live online event.
How can investors access Lifecore Biomedical’s (LFCR) Q2 2026 earnings webcast?
Investors can access Lifecore Biomedical’s Q2 2026 webcast via the Investor Events & Presentations page on the company’s website. According to Lifecore, this page will host both the live and archived webcast streams.
Will a replay of Lifecore Biomedical’s August 5, 2026 earnings webcast be available?
Yes, a replay will be available. According to Lifecore, an archived version of the August 5, 2026 webcast will be accessible on the company’s website for 30 days following the live presentation.
What does Lifecore Biomedical do as an injectables CDMO (NASDAQ: LFCR)?
Lifecore Biomedical is a fully integrated injectables contract development and manufacturing organization. According to Lifecore, it develops and performs fill-finish of sterile injectable products and manufactures injectable-grade hyaluronic acid for biopharmaceutical partners.
Where can I find more investor information about Lifecore Biomedical (LFCR)?
Investor information is available on Lifecore Biomedical’s website, including the Investor Events & Presentations section. According to Lifecore, this area hosts webcasts, presentations, and related financial communications for shareholders and analysts.
